As a result of our R&D activities, we have a wide portfolio of patents, some of them licensed, and others available to be applied in innovative business projects.


Since 2015, we have managed more than 2.5 million euros of investment in start-ups such as:

Created with the objective of applying PLA-Premium technology, which allows the development of biodegradable plastics with the potential to become a viable substitute for standard plastics in many applications.

The PLA-Premium technology is patented and ADBioplastics has the exclusive license for its commercial exploitation worldwide.

Its testers are the first European transport simulation testing technologies capable of simulating in a real way the physical and mechanical risks experienced by goods during the distribution cycle.

These solutions allow companies to optimize their packaging while increasing safety and sustainability and reducing costs. They also help comply with the 2014/47 EU directive on roadside technical inspections of commercial vehicles circulating in the European Union, as well as with the most important tests and procedures -including ISTA, ASTM, ISO, EN, or EUMOS.

Devoted to the development of devices that provide accurate information on the concentration levels of nanoparticles and respirable dust in the air, as well as on the presence of COVID-19 in both ambient air and biological fluids.

Specialized in the evaluation of health risks related to nanoparticle exposure in industrial facilities and urban environments.